Brief: Cocrystal Pharma Collaborates With National Institute Of Allergy And Infectious Diseases

Cocrystal Pharma

21/04/2022 13:14

April 21 (Reuters) - Cocrystal Pharma Inc  COCP.O :
    * COCRYSTAL PHARMA COLLABORATES WITH THE NATIONAL INSTITUTE
OF
ALLERGY AND INFECTIOUS DISEASES TO EVALUATE COVID-19 PROTEASE
INHIBITORS
    * COCRYSTAL PHARMA INC - UNDER NIAID COLLABORATION,
COCRYSTAL HAS
PROVIDED ITS 3CL PROTEASE INHIBITORS
    * COCRYSTAL PHARMA - UNDER COLLABORATION NIAID WILL BE
RESPONSIBLE
FOR IN VITRO AND IN VIVO STUDIES EVALUATING ANTIVIRAL ACTIVITY
OF COMPOUNDS

Source text for Eikon:  ID:nGNX3rWslT 
Further company coverage:  COCP.O 

 ((reuters.briefs@thomsonreuters.com;))